The Role of Enzalutamide 160 mg in Hormonal Therapy for Prostate Cancer

Enzalutamide is often a key player in hormonal therapy for prostate cancer. Hormonal therapy works by reducing the levels of testosterone or blocking its effects, thus slowing or stopping the growth of prostate cancer cells. Enzalutamide specifically targets androgen receptors, preventing them from stimulating cancer cell growth. Patients who have developed resistance to traditional hormone therapy often benefit from Enzalutamide, particularly when combined with other treatments like chemotherapy or immunotherapy.